LFCR
Income statement / Annual
Last year (2026), Lifecore Biomedical Inc's total revenue was $129.46 M,
an increase of 0.46% from the previous year.
In 2026, Lifecore Biomedical Inc's net income was -$30.79 M.
See Lifecore Biomedical Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2026
|
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
12/31/2026 |
05/25/2025 |
05/26/2024 |
05/28/2023 |
05/29/2022 |
05/31/2021 |
05/31/2020 |
05/31/2019 |
05/31/2018 |
05/31/2017 |
| Operating Revenue |
$129.46 M |
$128.87 M |
$128.26 M |
$103.27 M |
$111.27 M |
$100.87 M |
$160.07 M |
$557.56 M |
$524.23 M |
$532.26 M |
| Cost of Revenue |
$88.85 M
|
$88.57 M
|
$86.41 M
|
$75.28 M
|
$72.20 M
|
$61.94 M
|
$120.68 M
|
$476.56 M
|
$445.89 M
|
$449.07 M
|
| Gross Profit |
$40.61 M
|
$40.30 M
|
$41.85 M
|
$27.99 M
|
$39.07 M
|
$38.94 M
|
$39.39 M
|
$81.00 M
|
$78.34 M
|
$83.19 M
|
| Gross Profit Ratio |
0.31
|
0.31
|
0.33
|
0.27
|
0.35
|
0.39
|
0.25
|
0.15
|
0.15
|
0.16
|
| Research and Development Expenses |
$8.51 M
|
$8.26 M
|
$8.58 M
|
$8.74 M
|
$7.84 M
|
$6.68 M
|
$7.58 M
|
$11.47 M
|
$12.80 M
|
$9.47 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$62.76 M
|
$50.55 M
|
$56.31 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$1.30 M
|
$1.40 M
|
$1.90 M
|
| Selling, General & Administrative Expenses |
$33.35 M
|
$44.05 M
|
$40.46 M
|
$38.97 M
|
$34.66 M
|
$27.72 M
|
$40.67 M
|
$64.06 M
|
$51.95 M
|
$58.21 M
|
| Other Expenses |
$0.00
|
$5.24 M
|
$1.66 M
|
$2.08 M
|
$8.36 M
|
$13.36 M
|
$17.01 M
|
$0.00
|
$0.00
|
-$333.00 K
|
| Operating Expenses |
$41.87 M
|
$57.54 M
|
$50.69 M
|
$49.78 M
|
$50.86 M
|
$47.76 M
|
$65.26 M
|
$75.53 M
|
$64.75 M
|
$67.68 M
|
| Cost And Expenses |
$130.72 M
|
$146.11 M
|
$137.11 M
|
$125.07 M
|
$123.06 M
|
$109.70 M
|
$185.94 M
|
$552.08 M
|
$510.64 M
|
$516.75 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$68.00 K
|
$81.00 K
|
$48.00 K
|
$72.00 K
|
$145.00 K
|
$211.00 K
|
$16.00 K
|
| Interest Expense |
$0.00
|
$21.84 M
|
$18.09 M
|
$17.65 M
|
$15.55 M
|
$8.93 M
|
$4.65 M
|
$5.23 M
|
$1.95 M
|
$1.83 M
|
| Depreciation & Amortization |
$9.50 M
|
$8.03 M
|
$8.00 M
|
$13.18 M
|
$18.06 M
|
$19.87 M
|
$18.84 M
|
$14.60 M
|
$11.97 M
|
$10.68 M
|
| EBITDA |
$8.24 M |
-$8.81 M |
$35.60 M |
-$33.17 M |
$12.84 M |
-$987.00 K |
-$7.16 M |
$23.47 M |
$24.99 M |
$26.68 M |
| EBITDA Ratio |
0.06
|
-0.07
|
0.28
|
-0.32
|
0.12
|
-0.01
|
-0.04
|
0.04
|
0.05
|
0.05
|
| Operating Income Ratio |
-0.01
|
-0.13
|
-0.07
|
-0.21
|
-0.11
|
-0.09
|
-0.16
|
-0.01
|
0.02
|
0.03
|
| Total Other Income/Expenses Net |
-$28.96 M
|
-$21.43 M
|
$18.36 M
|
-$42.13 M
|
-$8.90 M
|
-$20.96 M
|
-$4.77 M
|
-$1.84 M
|
$2.81 M
|
-$493.00 K
|
| Income Before Tax |
-$30.21 M
|
-$38.67 M
|
$9.51 M
|
-$63.93 M
|
-$20.69 M
|
-$29.79 M
|
-$30.65 M
|
$3.64 M
|
$16.40 M
|
$15.01 M
|
| Income Before Tax Ratio |
-0.23
|
-0.3
|
0.07
|
-0.62
|
-0.19
|
-0.3
|
-0.19
|
0.01
|
0.03
|
0.03
|
| Income Tax Expense |
$577.71 K
|
$43.00 K
|
$183.00 K
|
$308.00 K
|
-$5.21 M
|
-$6.35 M
|
-$8.77 M
|
$1.52 M
|
-$9.36 M
|
$4.34 M
|
| Net Income |
-$30.79 M
|
-$38.72 M
|
$12.01 M
|
-$99.56 M
|
-$116.72 M
|
-$32.29 M
|
-$38.19 M
|
$2.12 M
|
$24.83 M
|
$10.59 M
|
| Net Income Ratio |
-0.24
|
-0.3
|
0.09
|
-0.96
|
-1.05
|
-0.32
|
-0.24
|
0
|
0.05
|
0.02
|
| EPS |
-0.92 |
-1.27 |
0.39 |
-3.32 |
-3.97 |
-1.12 |
-1.31 |
0.0748 |
0.9 |
0.39 |
| EPS Diluted |
-0.93 |
-1.27 |
0.33 |
-3.32 |
-3.97 |
-1.12 |
-1.31 |
0.0742 |
0.89 |
0.38 |
| Weighted Average Shares Out |
$33.26 M
|
$34.82 M
|
$30.47 M
|
$29.96 M
|
$29.47 M
|
$29.29 M
|
$29.16 M
|
$28.36 M
|
$27.70 M
|
$27.50 M
|
| Weighted Average Shares Out Diluted |
$37.37 M
|
$34.82 M
|
$36.66 M
|
$29.96 M
|
$29.47 M
|
$29.29 M
|
$29.16 M
|
$28.61 M
|
$27.92 M
|
$27.65 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
